Ardelyx, Inc.
NasdaqGM:ARDX
Sector
Location
Market Cap
USD 1.03 B
Share Price
USD 4.29
Avg Daily Volume
5,388,045
Change (1 day)
-1.61%
Change (1 year)
-21.86%
Change (YTD)
-15.38%
Ardelyx, Inc. Cash Flow Statement 2015 - 2025
This table shows the Cash Flow Statement for Ardelyx, Inc. going from 2015 until 2025. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
BioMarin Pharmaceutical Inc.
USD 59.01
BMRN
-0.75
-1.26%
Kyowa Kirin Co., Ltd.
USD 17.38
4151.T
-0.12
-0.67%
Abbott India Limited
USD 390.29
ABBOTINDIA.NS
-9.59
-2.40%
Sichuan Kelun Pharmaceutical Co., Ltd.
USD 4.91
002422.SZ
+0.03
0.69%
Chengdu Kanghong Pharmaceutical Group Co., Ltd
USD 5.62
002773.SZ
-0.09
-1.63%
Livzon Pharmaceutical Group Inc.
USD 4.98
1513.HK
-0.04
-0.76%
SCHOTT Pharma AG & Co. KGaA
USD 30.53
1SXP.F
+0.63
2.10%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
USD 7.39
688336.SS
-0.79
-9.71%
China Medical System Holdings Limited
USD 1.70
0867.HK
+0.01
0.60%
Gland Pharma Limited
USD 23.32
GLAND.NS
-0.02
-0.08%
Beijing Aosaikang Pharmaceutical Co., Ltd.
USD 3.65
002755.SZ
-0.11
-3.01%
Jilin Aodong Pharmaceutical Group Co., Ltd.
USD 2.66
000623.SZ
-0.03
-1.28%
China Resources Double-Crane Pharmaceutical Co.,Ltd.
USD 2.72
600062.SS
-0.01
-0.35%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd
USD 1.61
603707.SS
-0.02
-1.05%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
USD 0.84
9989.HK
-0.02
-2.79%